---
$id: https://graph.org.ai/products/commodity/51302308
$type: Product
source: UNSPSC
code: "51302308"
title: "Clotrimazole"
class: "51302300"
classTitle: "Antifungal imidazoles"
family: "51300000"
familyTitle: "Antifungal drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Clotrimazole

**UNSPSC Code**: 51302308
**Class**: [Antifungal imidazoles](Antifungal imidazoles.mdx)
**Family**: [Antifungal drugs](../Antifungal drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antifungal agent with the molecular formula C22H17ClN2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G07GZ97H65, chemically known as 1-(o-chloro-alpha,alpha-diphenylbenzyl)imidazole but generally known as clotrimazole, which bears US NIH Compound Identifier 2812. European Medicines Agency schedules Clotrimazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06777MIG. The term CLOTRIMAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , No. 10 1971, List 11). World Health Organization schedules clotrimazole in its Anatomical Therapeutic Chemical (ATC) Classification. CLOTRIMAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule clotrimazole under HS 29332990 and SITC 51573. As of Q4 2014, CLOTRIMAZOLE remains the US FDA Preferred Term for this commodity. Clotrimazole bears US NLM identifiers UMLS ID C0009074 and NCI Concept Code C381. SMILES: CLC1C(C(N2CCNC2)(C2CCCCC2)C2CCCCC2)CCCC1.

